Zydus Lifesciences’ Biotech Park facility gets clean chit in USFDA inspection

14 Jun 2023 , 12:21 PM

Zydus Lifesciences Ltd. announced today that the group’s injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad, was inspected by the USFDA.

USFDA conducted the inspection between June 5 to June 13, 2023. The company said that the cGMP inspection resulted in no observations.

The Zydus Group is a worldwide life sciences company focused on enabling individuals to live healthier and more satisfying lives. With a core objective of empowering people, the company engages in innovative practices to discover, develop, manufacture, and market a diverse portfolio of healthcare therapies.

Following this development, Zydus Lifesciences was trading 0.75% higher at Rs 521.55, against the previous close of Rs 517.65 on NSE. The counter touched an intraday high and low of Rs 523.90 and Rs 515.60 respectively.

For feedback and suggestions, write to us at [e-mail]